Table 1.
Baseline population characteristics, comorbidities, and symptoms of control and HD-groups.
| Control group (n = 41) |
Hemodialysis (HD-group) (n = 243) |
||
|---|---|---|---|
| Variable | Median (IQR) or mean ± SD | Median (IQR) or mean ± SD | p Value |
| Age [years] | 47 (41–65) | 58 (45–64) | 0.1171 |
| Sex [males/females] | 22/19 | 144/99 | 0.4994 |
| BMI [kg/m2] | 24.2 (21.5–28.3) | 26.3 (23.9–29.1) | 0.0241 |
| Serum creatinine [mg/dl] | 1.25 (1.06–1.65) | 1.45 (1.2–1.66) | 0.3324 |
| Dialysis vintage [months] | 18 (10–38) | 24 (13–38) | 0.1369 |
| Time from KTx to visit [months] | 92 (61–154) | 79 (32–144) | 0.0987 |
| LVD-36 score* [%] | 6.9 (0–19.4) | 25 (11.1–41.7) | 0.0001 |
| Comorbidities and prevalence of symptoms [n, %] | |||
| Heart failure | 4 (9.7%) | 39 (16.1%) | 0.4212 |
| Coronary artery disease | 2 (4.9%) | 39 (16.1%) | 0.1005 |
| Diabetes | 13 (31.7%) | 56 (23%) | 0.2410 |
| Smoker | 2 (4.9%) | 17 (7%) | 0.8696 |
| History of smoking | 8 (19.5%) | 87 (35.8%) | 0.0478 |
| Dyspnea | 2 (4.9%) | 40 (16.5%) | 0.0901 |
| Lower extremities edema | 8 (19.5%) | 72 (29.6%) | 0.1247 |
| Fatigue | 9 (21.9%) | 93 (38.3%) | 0.0526 |
| Worse exercise tolerance | 16 (39%) | 109 (44.8%) | 0.5026 |
| Palpitations | 7 (17.1%) | 61 (25.1%) | 0.3253 |
| Number of symptomatic patients | 22 (53.7%) | 154 (63.4%) | 0.2966 |
*LVD-36 scores were given only for symptomatic patients.